• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Animal & Veterinary

  • Print
  • Share
  • E-mail

FDA Issues Final Guidance for Renderers on Substances Prohibited From Use in Animal Food or Feed

April 30, 2009

The Food and Drug Administration (FDA) today issued a final guidance document, "Small Entities Compliance Guide for Renderers – Substances Prohibited from use in Animal Food or Feed," to provide guidance on the requirements of the final rule published in the Federal Register of April 25, 2008. This rule will further protect consumers against bovine spongiform encephalopathy (BSE), otherwise known as 'mad cow disease.'

The purpose of the guidance document is to help rendering firms comply with the rule that became effective April 27, 2009. The guidance should also help slaughter facilities and farms supplying offal and dead livestock to the renderers understand their obligations under the rule. A copy of the final guidance can be found on our guidance page.

The added measure of excluding high-risk materials from all animal feeds addresses risks associated with accidental feeding of such material to cattle, which could occur through cross-contamination of ruminant feed with non-ruminant feed or feed ingredients during manufacture and transport, or through misfeeding of non-ruminant feed to ruminants on the farm.

Comments on this guidance may be submitted any time to the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Room 1061, Rockville, MD 20852. Comments may also be submitted electronically at Regulations.gov. All written comments should be identified with Docket No. FDA-2008-D-0597.

For additional information on BSE and the final rule, please see our BSE page.

For questions regarding this final document, please contact Shannon Jordre at FDA’s Center for Veterinary Medicine, 240-276-9229, shannon.jordre@fda.hhs.gov.


Contact FDA

240-276-9115 FAX
Issued by: FDA, Center for Veterinary Medicine

Communications Staff, HFV-12

7519 Standish Place

Rockville, MD 20855